Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
Early data show faster viral clearance and favourable safety in mild to moderate COVID‑19
Read More
Author: John Pinching
FDA approves once‑weekly Sogroya for wider paediatric use
New authorisation extends treatment to children with ISS, SGA and Noonan syndrome
Read More
SolasCure trial shows faster healing with Aurase Wound Gel
Phase 2 study reports significantly accelerated debridement and wound repair in venous leg ulcers
Read More
Gilead data show investigational HIV combination maintains viral suppression
New phase 3 results highlight potential alternative for adults switching from complex regimens
Read More
Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
More than 200 participants enrolled as company targets topline data by end of 2026
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
